

GP Investments Dumps Entire Holding In FTSE 250-Listed RHI Magnesita


(Sharecast News) - Whitbread: Barclays upgrades to overweight with a target price of 4,900p.


UK BROKER RATINGS SUMMARY: Berkeley Gets Cut; Barclays Likes Whitbread


RHI Magnesita Production Optimisation To Help Improve Margins


UK BROKER RATINGS SUMMARY: RBC Likes Flutter And GVC Among Bookmakers


(Sharecast News) - AstraZeneca: Liberum upgrades to buy with a target price of 8,250p.


(Sharecast News) - Reckitt Benckiser: UBS downgrades to neutral with a target price of 6,200p.


UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped